216 related articles for article (PubMed ID: 5818350)
1. Jeryl Lynn strain live mumps virus vaccine. Durable immunity for three years following vaccination.
Weibel RE; Buynak EB; Whitman JE; Leagus MB; Stokes J; Hilleman MR
JAMA; 1969 Mar; 207(9):1667-70. PubMed ID: 5818350
[No Abstract] [Full Text] [Related]
2. Persistence of immunity four years following Jeryl Lynn strain live mumps virus vaccine.
Weibel RE; Buynak EB; Stokes J; Hilleman MR
Pediatrics; 1970 May; 45(5):821-6. PubMed ID: 5444402
[No Abstract] [Full Text] [Related]
3. Evaluation of a live attenuated mumps vaccine (Jeryl Lynn). With observations on the optimal time for testing serologic response.
Brunell PA; Brickman A; Steinberg S
Am J Dis Child; 1969 Sep; 118(3):435-40. PubMed ID: 5812074
[No Abstract] [Full Text] [Related]
4. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak.
Rubin SA; Qi L; Audet SA; Sullivan B; Carbone KM; Bellini WJ; Rota PA; Sirota L; Beeler J
J Infect Dis; 2008 Aug; 198(4):508-15. PubMed ID: 18558869
[TBL] [Abstract][Full Text] [Related]
5. A field trial with live attenuated mumps virus vaccine: a serological study.
Rossier E; Meunier J; Baker F; Marchessault V
Can J Microbiol; 1971 Jul; 17(7):929-34. PubMed ID: 5094603
[No Abstract] [Full Text] [Related]
6. Clinical trial of new attenuated mumps virus vaccine (Jeryl Lynn strain): preliminary report.
Pagano JS; Levine RH; Sugg WC; Finger JA
Prog Immunobiol Stand; 1967; 3():196-202. PubMed ID: 4908595
[No Abstract] [Full Text] [Related]
7. Jeryl Lynn Strain Live Attenuated Mumps Virus vaccine in a private pediatric practice.
Nickey LN; Huchton P; McGee WG
South Med J; 1970 Mar; 63(3):306-8. PubMed ID: 4905918
[No Abstract] [Full Text] [Related]
8. [Anti-mumps vaccination with a live attenuated vaccine in a children's collective].
Drouhet V; Celers J; Minvielle A
Bull Acad Natl Med; 1970 Jun; 154(23):570-6. PubMed ID: 4922864
[No Abstract] [Full Text] [Related]
9. Jeryl Lynn strain live attenuated mumps virus vaccine. Durability of immunity following administration.
Weibel RE; Stokes J; Buynak EB; Leagus MB; Hilleman MR
JAMA; 1968 Jan; 203(1):14-8. PubMed ID: 5694077
[No Abstract] [Full Text] [Related]
10. Studies on live mumps virus vaccine. 3. Evaluation of newly developed live mumps virus vaccine.
Yamanishi K; Takahashi M; Kurimura T; Ueda S; Minekawa Y
Biken J; 1970 Sep; 13(3):157-61. PubMed ID: 4992054
[No Abstract] [Full Text] [Related]
11. Comparative efficacy of Rubini, Jeryl-Lynn and Urabe mumps vaccine in an Asian population.
Ong G; Goh KT; Ma S; Chew SK
J Infect; 2005 Nov; 51(4):294-8. PubMed ID: 16291282
[TBL] [Abstract][Full Text] [Related]
12. Use of attenuated live mumps virus vaccine during a "virgin soil" epidemic of mumps on St. Paul Island, Alaska.
Maynard JE; Shramek G; Noble GR; Deinhardt F; Clark P
Am J Epidemiol; 1970 Nov; 92(5):301-6. PubMed ID: 5473777
[No Abstract] [Full Text] [Related]
13. Infants' responses to live, attenuated, B level, Jeryl Lynn mumps vaccine.
Wilkins J; Williams FF; Wehrle PF
Am J Dis Child; 1972 Jul; 124(1):66-7. PubMed ID: 5033752
[No Abstract] [Full Text] [Related]
14. Vaccination of school children with live mumps virus vaccine.
Furesz J; Nagler FP
Can Med Assoc J; 1970 May; 102(11):1153-5. PubMed ID: 5420994
[TBL] [Abstract][Full Text] [Related]
15. The immunizing effect and reactogenicity of two live attenuated mumps virus vaccines in Swedish schoolchildren.
Christenson B; Heller L; Böttiger M
J Biol Stand; 1983 Oct; 11(4):323-31. PubMed ID: 6643511
[TBL] [Abstract][Full Text] [Related]
16. [Anti-mumps vaccination with live attenuated vaccine in a children's community].
Drouhet V; Celers J; Minvielle A; Lévy-Thierry S
Ann Pediatr (Paris); 1971 Apr; 18(4):277-85. PubMed ID: 5574000
[No Abstract] [Full Text] [Related]
17. Clinical studies with virulent and attenuated mumps viruses.
Ennis FA; Douglas RD; Hopps HE; Meyer HM; Brown ER; Hobbins TE; Biehusen FC
Am J Epidemiol; 1969 Feb; 89(2):176-83. PubMed ID: 5765957
[No Abstract] [Full Text] [Related]
18. Development and biological properties of a new live attenuated mumps vaccine.
Saika S; Kidokoro M; Kubonoya H; Ito K; Ohkawa T; Aoki A; Nagata N; Suzuki K
Comp Immunol Microbiol Infect Dis; 2006; 29(2-3):89-99. PubMed ID: 16647119
[TBL] [Abstract][Full Text] [Related]
19. Studies on live attenuated mumps vaccine. II. Follow-up study on the efficacy of Biken Vaccine.
Isomura S; Ozaki T; Morishima T; Nagayoshi S; An S
Biken J; 1976 Sep; 19(3):115-8. PubMed ID: 1016214
[TBL] [Abstract][Full Text] [Related]
20. Persistence of immunity following monovalent and combined live measles, mumps, and rubella virus vaccines.
Weibel RE; Buynak EB; Stokes J; Hilleman MR
Pediatrics; 1973 Mar; 51(3):467-75. PubMed ID: 4707864
[No Abstract] [Full Text] [Related]
[Next] [New Search]
